CN Patent

CN115666570A — 瑞德西韦治疗方法

Assigned to Gilead Sciences Inc · Expires 2023-01-31 · 3y expired

What this patent protects

本文提供了治疗或预防受试者中的病毒感染的方法，该方法包括施用式(I)、式(Ia)或式(Ib)的化合物或其药学上可接受的盐，其中该受试者未用氯喹或其类似物或盐治疗。

USPTO Abstract

本文提供了治疗或预防受试者中的病毒感染的方法，该方法包括施用式(I)、式(Ia)或式(Ib)的化合物或其药学上可接受的盐，其中该受试者未用氯喹或其类似物或盐治疗。

Drugs covered by this patent

Patent Metadata

Patent number
CN115666570A
Jurisdiction
CN
Classification
—
Expires
2023-01-31
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.